Views on and experiences with medicinal cannabis among Canadian veterans who live with pain: A qualitative study

References

• VanDenKerkhof EG, VanTil L, Thompson JM, Sweet J, Hopman WM, Carley ME, Sudom K. Pain in Canadian veterans: analysis of data from the survey on transition to civilian life. Pain Res Manage. 2015;20(2):89–21. doi:10.1155/2015/763768.
   PubMed Web of Science ®Google Scholar
• VAC Research Directorate. Chronic pain in Veterans. Ottawa (ON): Veterans Affairs Canada (VAC); 2018.
   Google Scholar
• Foley HE, Knight JC, Ploughman M, Asghari S, Audas R. Association of chronic pain with comorbidities and health care utilization: a retrospective cohort study using health administrative data. Pain. 2021;162(11):2737–49. doi:10.1097/j.pain.0000000000002264.
   PubMed Web of Science ®Google Scholar
• Perera E, Thompson JM, Asmundson GJ, El-Gabalawy R, Afifi TO, Sareen J, Bolton S-L. Chronic pain: the Canadian Armed Forces members and Veterans mental health follow-up survey. J Mil Veteran Fam. 2021;7(S2):29–42. doi:10.3138/jmvfh-2021-0051.
   Google Scholar
• Travaglini LE, Cosgrave J, Klingaman EA. Pain and sleep problems predict quality of life for veterans with serious mental illness. Psychiatr Rehabil J. 2019;42(3):229. doi:10.1037/prj0000358.
   PubMed Web of Science ®Google Scholar
• Berey BL, Aston ER, Kearns NT, McGeary JE, Borsari B, Metrik J. Prospective associations between sleep disturbances and cannabis use among Veterans: a behavioral economic approach. Addict Behav. 2022;134:107424. doi:10.1016/j.addbeh.2022.107424.
   PubMed Web of Science ®Google Scholar
• Afolalu EF, Ramlee F, Tang NKY. Effects of sleep changes on pain-related health outcomes in the general population: a systematic review of longitudinal studies with exploratory meta-analysis. Sleep Med Rev. 2018;39:82–97. doi:10.1016/j.smrv.2017.08.001.
   PubMed Web of Science ®Google Scholar
• Saconi B, Polomano RC, Compton PC, McPhillips MV, Kuna ST, Sawyer AM. The influence of sleep disturbances and sleep disorders on pain outcomes among veterans: a systematic scoping review. Sleep Med Rev. 2021;56:101411. doi:10.1016/j.smrv.2020.101411.
   PubMed Web of Science ®Google Scholar
• Qureshi AR, Makanjuola O, Neumark S, Garas A, Wang L, Busse JW. Research priorities among Canadian military Veterans living with chronic pain: a cross-sectional survey. Mil Med. 2022. doi:10.1093/milmed/usac309.
   PubMed Web of Science ®Google Scholar
• Ziemianski D, Ware MA. Canada’s marihuana for medical purposes regulations: a synopsis for health professionals. J Hosp Adm. 2015;4(5):79. doi:10.5430/jha.v4n5p79.
   Google Scholar
• VAC Research Directorate. Cannabis for medical purposes. Ottawa (ON): Veterans Affairs Canada (VAC); 2022.
   Google Scholar
• VAC. Cannabis for medical purposes - revised reimbursement policy. Ottawa (ON): Veterans Affairs Canada (VAC), ed; 2019.
   Google Scholar
• Government of Canada. Cannabis Act. Ottawa (ON): Government of Canada; 2018
   Google Scholar
• Turna J, MacKillop J. Cannabis use among military veterans: a great deal to gain or lose? Clin Psychol Rev. 2021;84:101958. doi:10.1016/j.cpr.2021.101958.
   PubMed Web of Science ®Google Scholar
• Aviram J, Samuelly-Leichtag G. Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2017;20(6):E755–E96. doi:10.36076/ppj.20.5.E755.
   PubMed Web of Science ®Google Scholar
• Abrams DI. The therapeutic effects of Cannabis and cannabinoids: an update from the national academies of sciences, engineering and medicine report. Eur J Intern Med. 2018;49:7–11. doi:10.1016/j.ejim.2018.01.003.
   PubMed Web of Science ®Google Scholar
• Banerjee S, McCormack S. Medical cannabis for the treatment of chronic pain: a review of clinical effectiveness and guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jul 24.
   Google Scholar
• Wilkinson ST, van Schalkwyk GI, Davidson L, D’Souza DC. The formation of marijuana risk perception in a population of substance abusing patients. Psychiatr Q. 2016;87(1):177–87. doi:10.1007/s11126-015-9369-z.
   PubMed Web of Science ®Google Scholar
• Croulet J. Perceptions of cannabis use in combat Veterans: A cross-sectional case study [ Doctoral dissertation]. Northcentral University; 2018.
   Google Scholar
• Clary K, Habbal M, Smith D, Fratila I. The green sheep: exploring the perceived risks and benefits of cannabis among young military members and Veterans. Cannabis. 2021;4(2):31–46. doi:10.26828/cannabis/2021.02.003.
   PubMedGoogle Scholar
• Clary KL, Kang H, Quintero Silva L, Bobitt J. Weeding out the stigma: older Veterans in Illinois share their experiences using medical cannabis. J Psychoactive Drugs. 2022;1–8. doi:10.1080/02791072.2022.2082901.
   Web of Science ®Google Scholar
• Earleywine M, Bolles JR. Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation. J Psychoactive Drugs. 2014;46(3):171–77. doi:10.1080/02791072.2014.920118.
   PubMed Web of Science ®Google Scholar
• Baron EP. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and cannabis science. Headache. 2018;58:1139–86.
   PubMed Web of Science ®Google Scholar
• Bonn-Miller MO, Babson KA, Vandrey R. Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. Drug Alcohol Depend. 2014;136:162–65. doi:10.1016/j.drugalcdep.2013.12.008.
   PubMed Web of Science ®Google Scholar
• Tull MT, Jakupcak M, Paulson A, Gratz KL. The role of emotional inexpressivity and experiential avoidance in the relationship between posttraumatic stress disorder symptom severity and aggressive behavior among men exposed to interpersonal violence. Anxiety Stress Coping. 2007;20(4):337–51. doi:10.1080/10615800701379249.
   PubMed Web of Science ®Google Scholar
• VAC Research Directorate. Measuring Veteran well-being. Ottawa (ON): Veterans Affairs Canada (VAC), ed; 2019.
   Google Scholar
• Guest G, Namey E, McKenna K. How many focus groups are enough? Building an evidence base for nonprobability sample sizes. Field Methods. 2017;29(1):3–22. doi:10.1177/1525822X16639015.
   Web of Science ®Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82. doi:10.1177/1525822X05279903.
   Web of Science ®Google Scholar
• Government of Canada. Statistics of women in the Canadian armed forces. Ottawa (ON): Government of Canada; 2022.
   Google Scholar
• NVivo. Ver. 14.0 [software]. Denver (CO): Lumivero; 2023 Mar 14.
   Google Scholar
• Cotter A. Sexual misconduct in the Canadian armed forces regular force. Ottawa (ON): Statistics Canada; 2018.
   Google Scholar
• DeCuir-Gunby JT, Marshall PL, McCulloch AW. Developing and using a codebook for the analysis of interview data: an example from a professional development research project. Field Methods. 2011;23(2):136–55. doi:10.1177/1525822X10388468.
   Web of Science ®Google Scholar
• Glaser BG. The constant comparative method of qualitative analysis. Soc Probl. 1965;12(4):436–45. doi:10.2307/798843.
   Web of Science ®Google Scholar
• Glaser BG, Strauss AL, Strutzel E. The discovery of grounded theory; strategies for qualitative research. Nurs Res. 1968;17(4):364. doi:10.1097/00006199-196807000-00014.
   Web of Science ®Google Scholar
• VAC. Demographics. Ottawa (ON): Veterans Affairs Canada (VAC), ed; 2021.
   Google Scholar
• Krediet E, Janssen DG, Heerdink ER, Egberts TC, Vermetten E. Experiences with medical cannabis in the treatment of veterans with PTSD: results from a focus group discussion. Eur Neuropsychopharmacol. 2020;36:244–54. doi:10.1016/j.euroneuro.2020.04.009.
   PubMed Web of Science ®Google Scholar
• Baumbusch J, Sloan Yip I. Exploring new use of cannabis among older adults. Clin Gerontol. 2021;44(1):25–31. doi:10.1080/07317115.2020.1746720.
   PubMed Web of Science ®Google Scholar
• Benedetti F, Carlino E, Pollo A. How placebos change the patient’s brain. Neuropsychopharmacology. 2011;36(1):339–54. doi:10.1038/npp.2010.81.
   PubMed Web of Science ®Google Scholar
• Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med. 2011;17(10):1228–30. doi:10.1038/nm.2435.
   PubMed Web of Science ®Google Scholar
• Casarett D. The achilles heel of medical cannabis research—inadequate blinding of placebo-controlled trials. JAMA Intern Med. 2018;178(1):9–10. doi:10.1001/jamainternmed.2017.5308.
   PubMed Web of Science ®Google Scholar
• Dondanville KA, Blankenship AE, Molino A, Resick PA, Wachen JS, Mintz J, Yarvis JS, Litz BT, Borah EV, Roache JD. Qualitative examination of cognitive change during PTSD treatment for active duty service members. Behav Res Ther. 2016;79:1–6. doi:10.1016/j.brat.2016.01.003.
   PubMed Web of Science ®Google Scholar
• Haney M, Evins AE. Does cannabis cause, exacerbate or ameliorate psychiatric disorders? An oversimplified debate discussed. Neuropsychopharmacology. 2016;41(2):393–401. doi:10.1038/npp.2015.251.
   PubMed Web of Science ®Google Scholar
• Leos‐Toro C, Shiplo S, Hammond D. Perceived support for medical cannabis use among approved medical cannabis users in Canada. Drug Alcohol Rev. 2018;37(5):627–36. doi:10.1111/dar.12823.
   PubMed Web of Science ®Google Scholar
• Ng JY, Gilotra K, Usman S, Chang Y, Busse JW. Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study. Can Med Assoc J. 2021;9:E342–E8.
   Google Scholar
• Lough S. Private cannabis clinics offer clients access. Can Med Assoc. 2015;187(12):865–66. doi:10.1503/cmaj.109-5119.
   PubMed Web of Science ®Google Scholar
• Prosk E, Arboleda MF, Rapin L, El Hage C, Dworkind M. The model of care at a leading medical cannabis clinic in Canada. Complement Ther Med. 2021;60:102740. doi:10.1016/j.ctim.2021.102740.
   PubMed Web of Science ®Google Scholar
• The College of Family Physicians of Canada. Family doctor shortage in Canada. 2022 [accessed 2022 Nov 14]. https://www.cfpc.ca/en/news-and-events/news-events/news-events/news-releases/2022/family-doctor-shortage-in-canada.
   Google Scholar
• Kahan M, Srivastava A, Clarke S. Cannabis industry and medical cannabis clinics need regulation. Can Fam Physician. 2019;65:864–68.
   PubMed Web of Science ®Google Scholar
• Hammond D. Communicating THC levels and ‘dose’to consumers: implications for product labelling and packaging of cannabis products in regulated markets. Int J Drug Policy. 2021;91:102509. doi:10.1016/j.drugpo.2019.07.004.
   PubMed Web of Science ®Google Scholar
• Nyland CR, Moyer DC. Regulating for safety: cannabidiol dose in food: a review. J Food Prot. 2022;85(9):1355–69. doi:10.4315/JFP-21-374.
   PubMed Web of Science ®Google Scholar
• MacCallum CA, Lo LA, Boivin M. “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. Eur J Intern Med. 2021;89:10–18. doi:10.1016/j.ejim.2021.05.002.
   PubMed Web of Science ®Google Scholar
• Fischer B, Russell C, Sabioni P, Van Den Brink W, Le Foll B, Hall W, Rehm J, Room R. Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations. Am J Public Health. 2017;107(8):e1–e12. doi:10.2105/AJPH.2017.303818.
   PubMed Web of Science ®Google Scholar
• Sihota A, Smith BK, Ahmed SA, Bell A, Blain A, Clarke H, Cooper ZD, Cyr C, Daeninck P, Deshpande A. Consensus‐based recommendations for titrating cannabinoids and tapering opioids for chronic pain control. Int J Clin Pract. 2021;75(8):e13871. doi:10.1111/ijcp.13871.
   PubMed Web of Science ®Google Scholar
• Bhaskar A, Bell A, Boivin M, Briques W, Brown M, Clarke H, Cyr C, Eisenberg E, de Oliveira Silva RF, Frohlich E. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res. 2021;3(1):1–12. doi:10.1186/s42238-021-00073-1.
   PubMedGoogle Scholar
• Busse JW, Vankrunkelsven P, Zeng L, Heen AF, Merglen A, Campbell F, Granan L-P, Aertgeerts B, Buchbinder R, Coen M. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline. BMJ. 2021;374:n2040. doi:10.1136/bmj.n2040.
   Google Scholar
• Gibson M, Williamson L, Henwood G, Chalmers D, Dell CA. Perceptions and use of alcohol and medical Cannabis among Canadian military veterans living with PTSD. J Veterans Stud. 2021;7(1):59. doi:10.21061/jvs.v7i1.200.
   Google Scholar
• Shanahan M, Cyrenne P. Cannabis policies in Canada: how will we know which is best? Int J Drug Policy. 2021;91:102556. doi:10.1016/j.drugpo.2019.09.004.
   PubMed Web of Science ®Google Scholar
• Ng JY, Homayouni P, Usman S, Gomes Z. The medical cannabis regulatory framework in Canada: a narrative review. Eur J Integr Med. 2022;50:102104. doi:10.1016/j.eujim.2022.102104.
   Web of Science ®Google Scholar
• Wickens CM, Stoduto G, Ilie G, Di Ciano P, McDonald AJ, Mistry A, Alawi A, Sharma S, Hamilton H, Nigatu YT. Driving under the influence of cannabis among recreational and medical cannabis users: a population study. J Transp Health. 2022;26:101402. doi:10.1016/j.jth.2022.101402.
   Web of Science ®Google Scholar
• Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. Bmj. 2012;344(feb09 2):e536. doi:10.1136/bmj.e536.
   PubMedGoogle Scholar
• Rogeberg O, Elvik R. The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction. 2016;111(8):1348–59. doi:10.1111/add.13347.
   PubMed Web of Science ®Google Scholar
• M-C L, Brady JE, DiMaggio CJ, Lusardi AR, Tzong KY, Li G. Marijuana use and motor vehicle crashes. Epidemiol Rev. 2012;34(1):65–72. doi:10.1093/epirev/mxr017.
   PubMed Web of Science ®Google Scholar
• Brands B, Di Ciano P, Mann RE. Cannabis, impaired driving, and road safety: an overview of key questions and issues. Front Psychiatry. 2021;12:641549. doi:10.3389/fpsyt.2021.641549.
   PubMed Web of Science ®Google Scholar
• Compton WM, Han B, Jones CM, Blanco C, Hughes A. Marijuana use and use disorders in adults in the USA, 2002–14: analysis of annual cross-sectional surveys. Lancet Psychiatry. 2016;3(10):954–64. doi:10.1016/S2215-0366(16)30208-5.
   PubMed Web of Science ®Google Scholar